Skip to search formSkip to main contentSkip to account menu

SB 210661

Known as: SB-210661 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

BenzofuransUrea
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Benzofuranyl ureas with potent cardiovascular teratogenicity in rats.
Studies of embryo-fetal development in rats were conducted with two 5-lipoxygenase inhibitors. SB-202235 (1,000 mg/kg/day) or SB… 
1998
1998
Aqueous Stability of SB 210661: Kinetics and Primary Degradation Mechanisms of an N‐Hydroxyurea‐containing 5‐Lipoxygenase Inhibitor
SB 210661, (S)‐N‐hydroxy‐N‐[2,3‐dihydro‐6‐(2,6‐difluorophenylmethoxy)‐3‐benzofuranyl]urea, is a potent and selective inhibitor of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)